Sunflower Therapeutics announces the first system delivery and installation of its Daisy Petal™ to the BioBuilder Education Foundation.

MEDFORD, Mass., May 19, 2025--Sunflower Therapeutics announces the first system delivery and installation of its Daisy Petal™ to the BioBuilder Education Foundation.

MEDFORD, Mass., May 19, 2025--(BUSINESS WIRE)--Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, ...

The first delivery and installation of the Daisy Petal™ to BioBuilder’s Learning Lab Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein ...

Researchers have developed a hollow fiber bioreactor that mimics a circulatory system, overcoming challenges in tissue thickness and nutrient delivery. This breakthrough enables the scalable ...

Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today its first distribution ...

Through this agreement, Sunflower will commercially launch its Daisy Petal™ Perfusion Bioreactor System in Asia, a significant step in the company’s ongoing product commercialization.

MEDFORD, Mass., February 26, 2025--Sunflower Therapeutics announced its first distribution agreement with PharmNXT Biotech to launch its Daisy Petal Perfusion Bioreactor System in Asia.